Reassessing Cryptosporidium Risk: Treatment Security, Regulatory Monitoring and Epidemiology

Price: £21  

Companies can re-assess sites designated as "at significant risk" to have them removed from the Regulatory monitoring category. The report reviews the Regulatory monitoring data for Cryptosporidium, examines approaches some companies have taken to reclassify or reduce risk, and evaluates the feasibility of identifying association between oocyst concentrations in water supplies and incidence of human cryptosporidiosis. The primary objective was to provide alternative or complementary approaches relating to water treatment plant operation, to allow companies to select those appropriate to specific sites.



UKWIR Reference :- 03/DW/06/16Published Date :- 21/07/2003
Retail Price (£) :- 21ISBN :- 1-84057-299-X